Clinical Trial Update: Treatment -Resistant Neovascular Age-Related Macular Degeneration [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating a treatment for treatment-resistant neovascular age-related macular degeneration has completed. The sponsor is Washington University …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Snippet

Sponsor: Washington University School of Medicine | Conditions: Macular Degeneration | Phase 1 | Status: COMPLETED